European Companies Search Engine
Spin-off: Sandoz Pharmaceuticals GmbH · Break-up: Sandoz Pharmaceuticals GmbH · Capital: €42M · Company statute Hrb9 Aug 2006 German Trade Register Announcements, Germany (02/08/2006)
Overview
Text
Salutas Pharma GmbH, Barleben (
Otto-von-Guericke-Allee 1, 39179 Barleben
). The Shareholders' Meeting of July 12, 2006 decided to increase the share capital by EUR 253,000 to EUR 42,000,000 for the purpose of carrying out the spin-off and amending Section 3 (share capital) of the Articles of Association. EUR 42,000.00. By way of spin-off pursuant to the spin-off agreement of July 12, 2006 and the resolution of its shareholders' meeting of July 12, 2006 and resolution of the shareholders' meeting of the transferring company of July 12, 2006 the company took over parts of the assets (gerlingen division) from the Sandoz Pharmaceuticals GmbH with its registered office in Ismaning, district of Munich (Amtsgericht München HRB 149255). The spin-off shall only become effective when it is entered in the register of the registered office of the transferring entity. Unregistered: The creditors of the entities participating in the spin-off must be declared in writing if they declare their claim in writing on the basis of reason and amount within six months of the date on which the registration of the spin-off pursuant to Section 125, 19 (3) of the UmwG is deemed to have been made public, provided that they cannot claim satisfaction. However, they are entitled to this right only if they demonstrate that the spin-off jeopardises the fulfilment of their claim.
This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Salutas Pharma GmbH, Barleben, Germany.
